These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34883275)

  • 21. Topical rebamipide treatment for superior limbic keratoconjunctivitis in patients with thyroid eye disease.
    Takahashi Y; Ichinose A; Kakizaki H
    Am J Ophthalmol; 2014 Apr; 157(4):807-812.e2. PubMed ID: 24412123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of 0.1% lodoxamide for the long-term treatment of superior limbic keratoconjunctivitis.
    Rodriguez-Garcia A; Macias-Rodriguez Y; Gonzalez-Gonzalez JM
    Int Ophthalmol; 2018 Jun; 38(3):1243-1249. PubMed ID: 28602013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The fine structure of nuclear changes in superior limbic keratoconjunctivitis.
    Collin HB; Donshik PC; Boruchoff SA; Foster CS; Cavanagh HD
    Invest Ophthalmol Vis Sci; 1978 Jan; 17(1):79-84. PubMed ID: 621134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superior limbic keratoconjunctivitis: Update on pathophysiology and management.
    Lee DH; Margolis MS; Iovieno A; Ling J; Ng T; Djalilian AR; Yeung SN
    Ocul Surf; 2023 Apr; 28():144-152. PubMed ID: 37011726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Superior limbic keratoconjunctivitis in association with scarring of the superior tarsal conjunctiva.
    Raber IM
    Cornea; 1996 May; 15(3):312-6. PubMed ID: 8713936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topical cyclosporine a in the treatment of superior limbic keratoconjunctivitis: a long-term follow-up.
    Sahin A; Bozkurt B; Irkec M
    Cornea; 2008 Feb; 27(2):193-5. PubMed ID: 18216575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lodoxamide tromethamine treatment for superior limbic keratoconjunctivitis.
    Grutzmacher RD; Foster RS; Feiler LS
    Am J Ophthalmol; 1995 Sep; 120(3):400-2. PubMed ID: 7661218
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjunctival resection treatment and ultrastructural histopathology of superior limbic keratoconjunctivitis.
    Donshik PC; Collin HB; Foster CS; Cavanagh HD; Boruchoff SA
    Am J Ophthalmol; 1978 Jan; 85(1):101-10. PubMed ID: 619676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical cyclosporine A 0.5% as a possible new treatment for superior limbic keratoconjunctivitis.
    Perry HD; Doshi-Carnevale S; Donnenfeld ED; Kornstein HS
    Ophthalmology; 2003 Aug; 110(8):1578-81. PubMed ID: 12917176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tear cytokine profiling in patients with superior limbic keratoconjunctivitis who underwent medical treatment or in conjunction with surgical management.
    Sun YC; Tang YH; Liou HM; Chen WL; Hu FR
    Br J Ophthalmol; 2020 May; 104(5):735-740. PubMed ID: 30926588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-beta2, tenascin, and integrin beta1 expression in superior limbic keratoconjunctivitis.
    Matsuda A; Tagawa Y; Matsuda H
    Jpn J Ophthalmol; 1999; 43(4):251-6. PubMed ID: 10482468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological aspects of superior limbic keratoconjunctivitis.
    Eiferman RA; Wilkins EL
    Can J Ophthalmol; 1979 Apr; 14(2):85-7. PubMed ID: 378334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Superior limbic keratoconjunctivitis in identical twins.
    Darrell RW
    Cornea; 1992 May; 11(3):262-3. PubMed ID: 1587136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokeratin and proliferative cell nuclear antigen expression in superior limbic keratoconjunctivitis.
    Matsuda A; Tagawa Y; Matsuda H
    Curr Eye Res; 1996 Oct; 15(10):1033-8. PubMed ID: 8921242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical approach with high-frequency radiowave electrosurgery for superior limbic keratoconjunctivitis.
    Ahn JM; Choi CY; Seo KY
    Cornea; 2014 Feb; 33(2):210-4. PubMed ID: 24322803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of involucrin by ocular surface epithelia of patients with benign and malignant disorders.
    Saika S; Minamide A; Tanaka T; Miyamoto T; Okada Y; Kawashima Y; Ohnishi Y; Ooshima A; Kao WW
    Curr Eye Res; 2000 Nov; 21(5):877-85. PubMed ID: 11262609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Inflammatory Infiltrate Correlates With Poor Symptomatic Improvement After Surgical Treatment for Superior Limbic Keratoconjunctivitis.
    Zoroquiain P; Sanft DM; Esposito E; Cheema D; Dias AB; Burnier MN
    Cornea; 2018 Apr; 37(4):495-500. PubMed ID: 29346129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a mucin-like glycoprotein produced by ocular surface epithelium in normal and keratinized cells.
    Watanabe H; Maeda N; Kiritoshi A; Hamano T; Shimomura Y; Tano Y
    Am J Ophthalmol; 1997 Dec; 124(6):751-7. PubMed ID: 9402820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior limbic keratoconjunctivitis in contact lens wearers.
    Sendele DD; Kenyon KR; Mobilia EF; Rosenthal P; Steinert R; Hanninen LA
    Ophthalmology; 1983 Jun; 90(6):616-22. PubMed ID: 6888855
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of matrix metalloproteinase-1 (MMP-1) and MMP-3 in superior limbic keratoconjunctivitis.
    Sun YC; Hsiao CH; Chen WL; Hu FR
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3701-5. PubMed ID: 21357403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.